Expressions of resistance proteins P-gp,BCRP and LRP:a comparison between primary and metastatic breast carcinoma
Yu Duan
Abstract
Yu Duan
Abstract
Objective To investigate the differences in expressions of P-glycoprotein(P-gp),breast cancer drug resistance protein(BCRP) and pulmonary resistance protein(LRP) between primary breast carcinoma and metastatic lymph nodes.Methods The expressions of P-gp,BCRP and LRP in breast cancer tissues,including 126 primary carcinoma and 66 metastasis lymph nodes,were determined immunohistochemically on formalin-fixed,paraffin-embedded tumor sections.Results(1)The positive expression rates of P-gp,BCRP and LRP were 41.27%(52/126),38.89%(49/126),and 65.87%(83/126) in primary breast carcinoma,and were 59.09%(39/66),63.64%(42/66),and 60.61%(40/66) in metastatic lymph nodes,respectively.The positive rates of P-gp and BCRP in the metastatic lymph nodes were significantly higher than those in primary cancer tissue(P0.05);there was no significant difference in expression of LRP(P0.05).(2) There was a poor consistency in P-gp and BCRP expression between the primary and metastatic sites(P0.01,Kappa value were 0.276 and 0.356);there was a consistency in LRP expression between the primary and metastatic sites(P0.05).(3) The co-expression rate of two resistance proteins in primary breast carcinoma was 35.71%(45/126),of three resistance proteins was 15.08%(19/126),and of two or three resistance proteins was 50.79%(64/126),being significantly higher than that of a single protein 33.33%(42/126,P0.05).The co-expression rate of two resistance proteins in metastasis lymph nodes was 53.03%(35/66),which was significantly higher than that of a single protein 27.27%(18/66,P0.05).The co-expression rate of three resistance proteins was 16.67%(11/66),two or three resistance proteins was 69.70%(46/66),which was significantly higher than that of a single protein(P0.01).Both the co-expression levels of two resistance proteins and two or three resistance proteins in metastatic lymph nodes were significantly higher than those in primary cancer(P0.05).(4)Kaplan-Meier analyses revealed that patients with P-gp,BCRP and LRP expressed in the metastatic lymph nodes had a lower 5-year survival rate compared with patients whose primary breast cancer being positive for them.Conclusion The expression of P-gp and BCRP is different between the primary and metastatic breast cancer sites,and there is no significant difference in LRP expression.Coordination of multi-protein expression is a major feature of resistance.Metastasis lymph nodes may have a stronger resistance.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the differences in expressions of P-glycoprotein(P-gp),breast cancer drug resistance protein(BCRP) and pulmonary resistance protein(LRP) between primary breast carcinoma and metastatic lymph nodes.Methods The expressions of P-gp,BCRP and LRP in breast cancer tissues,including 126 primary carcinoma and 66 metastasis lymph nodes,were determined immunohistochemically on formalin-fixed,paraffin-embedded tumor sections.Results(1)The positive expression rates of P-gp,BCRP and LRP were 41.27%(52/126),38.89%(49/126),and 65.87%(83/126) in primary breast carcinoma,and were 59.09%(39/66),63.64%(42/66),and 60.61%(40/66) in metastatic lymph nodes,respectively.The positive rates of P-gp and BCRP in the metastatic lymph nodes were significantly higher than those in primary cancer tissue(P0.05);there was no significant difference in expression of LRP(P0.05).(2) There was a poor consistency in P-gp and BCRP expression between the primary and metastatic sites(P0.01,Kappa value were 0.276 and 0.356);there was a consistency in LRP expression between the primary and metastatic sites(P0.05).(3) The co-expression rate of two resistance proteins in primary breast carcinoma was 35.71%(45/126),of three resistance proteins was 15.08%(19/126),and of two or three resistance proteins was 50.79%(64/126),being significantly higher than that of a single protein 33.33%(42/126,P0.05).The co-expression rate of two resistance proteins in metastasis lymph nodes was 53.03%(35/66),which was significantly higher than that of a single protein 27.27%(18/66,P0.05).The co-expression rate of three resistance proteins was 16.67%(11/66),two or three resistance proteins was 69.70%(46/66),which was significantly higher than that of a single protein(P0.01).Both the co-expression levels of two resistance proteins and two or three resistance proteins in metastatic lymph nodes were significantly higher than those in primary cancer(P0.05).(4)Kaplan-Meier analyses revealed that patients with P-gp,BCRP and LRP expressed in the metastatic lymph nodes had a lower 5-year survival rate compared with patients whose primary breast cancer being positive for them.Conclusion The expression of P-gp and BCRP is different between the primary and metastatic breast cancer sites,and there is no significant difference in LRP expression.Coordination of multi-protein expression is a major feature of resistance.Metastasis lymph nodes may have a stronger resistance.
Key concepts: Lymph, Abcg2, Breast carcinoma, Medicine, P-glycoprotein, Metastasis, Breast cancer, Carcinoma